These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31649528)

  • 21. Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control Trial.
    Bell SP; Schnipper JL; Goggins K; Bian A; Shintani A; Roumie CL; Dalal AK; Jacobson TA; Rask KJ; Vaccarino V; Gandhi TK; Labonville SA; Johnson D; Neal EB; Kripalani S;
    J Gen Intern Med; 2016 May; 31(5):470-7. PubMed ID: 26883526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Lindahl B; Baron T; Erlinge D; Hadziosmanovic N; Nordenskjöld A; Gard A; Jernberg T
    Circulation; 2017 Apr; 135(16):1481-1489. PubMed ID: 28179398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial.
    Murray MD; Young J; Hoke S; Tu W; Weiner M; Morrow D; Stroupe KT; Wu J; Clark D; Smith F; Gradus-Pizlo I; Weinberger M; Brater DC
    Ann Intern Med; 2007 May; 146(10):714-25. PubMed ID: 17502632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial.
    Martin P; Tamblyn R; Benedetti A; Ahmed S; Tannenbaum C
    JAMA; 2018 Nov; 320(18):1889-1898. PubMed ID: 30422193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of a WeChat-Based Tertiary A-Level Hospital Intervention on Medication Adherence and Risk Factor Control in Patients With Stable Coronary Artery Disease: Multicenter Prospective Study.
    Shi B; Liu X; Dong Q; Yang Y; Cai Z; Wang H; Yin D; Wang H; Dou K; Song W
    JMIR Mhealth Uhealth; 2021 Oct; 9(10):e32548. PubMed ID: 34569467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifaceted intervention including motivational interviewing to support medication adherence after stroke/transient ischemic attack: a randomized trial.
    Hedegaard U; Kjeldsen LJ; Pottegård A; Bak S; Hallas J
    Cerebrovasc Dis Extra; 2014; 4(3):221-34. PubMed ID: 25598772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial.
    Crotty M; Rowett D; Spurling L; Giles LC; Phillips PA
    Am J Geriatr Pharmacother; 2004 Dec; 2(4):257-64. PubMed ID: 15903284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study.
    Ferrières J; Lautsch D; Ambegaonkar BM; De Ferrari GM; Vyas A; Baxter CA; Bash LD; Velkovski-Rouyer M; Horack M; Almahmeed W; Chiang FT; Poh KK; Elisaf M; Brudi P; Gitt AK
    Int J Cardiol; 2018 Nov; 270():21-27. PubMed ID: 29934227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pharmacist care on medication adherence and cardiovascular outcomes among patients post-acute coronary syndrome: A systematic review.
    El Hajj MS; Jaam MJ; Awaisu A
    Res Social Adm Pharm; 2018 Jun; 14(6):507-520. PubMed ID: 28641999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacist role to enhance the prescribing of hospital discharge medications for patients after heart attack.
    Jabri AM; Assad HC; Al-Jumaili AA
    Saudi Pharm J; 2020 Apr; 28(4):473-479. PubMed ID: 32273807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Quasi-Randomized Controlled Trial of an Integrated Healthcare Model for Patients with Coronary Heart Disease.
    Cao G; Xie M; Xu Y; Huang J; Liang J; Tao B; Yan Q
    Rev Cardiovasc Med; 2022 Jul; 23(7):234. PubMed ID: 39076902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study.
    Gattis WA; Hasselblad V; Whellan DJ; O'Connor CM
    Arch Intern Med; 1999 Sep; 159(16):1939-45. PubMed ID: 10493325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the Interactive Web-Based Video "Mon Coeur, Mon BASIC" on Drug Adherence of Patients With Myocardial Infarction: Randomized Controlled Trial.
    Bruggmann C; Adjedj J; Sardy S; Muller O; Voirol P; Sadeghipour F
    J Med Internet Res; 2021 Aug; 23(8):e21938. PubMed ID: 34459744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
    Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barón AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K
    Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Physician-Pharmacist Participation in the Management of Ambulatory Cancer Pain Through a Digital Health Platform: Randomized Controlled Trial.
    Zhang L; McLeod HL; Liu KK; Liu WH; Huang HX; Huang YM; Sun SS; Chen XP; Chen Y; Liu FZ; Xiao J
    JMIR Mhealth Uhealth; 2021 Aug; 9(8):e24555. PubMed ID: 34398796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction.
    Faridi KF; Peterson ED; McCoy LA; Thomas L; Enriquez J; Wang TY
    JAMA Cardiol; 2016 May; 1(2):147-55. PubMed ID: 27437885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of pharmacist-led medication management in care transitions.
    Yang S
    BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention: A multicenter randomized controlled trial.
    Wang PL; Zhang L; Wang SL; Yang QN; Gao ZY; Du JP; Zhang DW; Fu CG; Gu F; Xu H; Li LZ; Wang CL; Shi DZ
    Chin J Integr Med; 2017 Oct; 23(10):740-746. PubMed ID: 27778264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.